Dr. Tom Shepherd has been appointed chief executive officer of Bioaster, a Technology Research Institute focused on infectious diseases and microbiology
Shepherd succeeds Jacques Berger who, following his retirement from his previous position as directeur général délégué of Sanofi Pasteur, had been asked to set up Bioaster’s corporate and laboratory operations and establish the foundations for its future growth into a leading research institute.
